HopeStage
Back to all studies
Active Not RecruitingNCT06317636

Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression

Medication studyAges 18–70United States
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Listed locations
StanfordSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 28, 2025
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
40
Sponsor
Stanford University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT06317636
Official title
Show the full official title

Randomized, Double-blind, Placebo-controlled, Single-center, Noninferiority Trial of Ketamine Given During Sedation to Patients With Chronic Pain and Depression

Recruitment & locations

Not recruiting

Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Does this study involve medication?

Yes. The study involves medication, including ketamine and Normal saline.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies